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Introduction
Periodontal therapy aims at removal of hard and soft de-
posits from the root surface.1 Hand and ultrasonic instru-
mentation for scaling and root planing (SRP) have shown 
to be effective approaches for nonsurgical periodontal 
therapy.2 Lasers have been suggested as a new alterna-
tive for treatment of periodontal disease.3 Diode laser, 
neodymium-doped: yttrium, aluminum and garnet laser 
(Nd:YAG), erbium-doped: yttrium, aluminum and gar-
net laser (Er:YAG) and carbon dioxide (CO2) laser4 with 
wavelengths (λ) ranging from 630 nm to 10600 nm are 
commonly used for periodontal therapy. Lasers have been 
considerably used due to their antibacterial potential by 
direct ablation, thermal denaturation, and destruction of 
bacterial cells.
Photodynamic therapy (PDT) combines the use of visi-
ble light and a photo sensitizer, to produce singlet oxygen 
molecules and free radicals which have an antimicrobi-
al effect.5 The use of helium/neon (He/Ne) laser or gal-
lium-aluminium arsenide (GaAlAs) laser with a suitable 
photo sensitizer showed a significant reduction of bac-
teria in subgingival plaque from subjects with chronic 
periodontitis.6 Bacteria associated with periodontal dis-
ease can also be killed through photosensitization using 
toluidine blue O with He/Ne laser.7 A positive effect on 
pocket depth reduction as well as improvement in clini-
cal levels and bleeding on probing (BOP) have also been 
reported.8,9 Lui et al showed a beneficial effect when they 
combined photodynamic and low level laser therapy in 
nonsurgical treatment of chronic periodontitis.10
Periodontitis is a disease with multi factorial etiology 
causing the destruction of supporting structures resulting 
in formation of periodontal pocket and loss of alveolar 
bone.11 The major determinant of this disease suscepti-
bility is the host immune inflammatory response to the 
subgingival biofilm. The pathogenesis of periodontitis 
involves role play of cytokines, produced by host defense 
cells in reaction to antigenic stimuli, which have a wide 
range of overlapping functions. These cytokines are sol-
uble proteins that paradoxically result in maximum tis-
sue damage leading to the clinical manifestation of the 
disease.
Interleukin-17 (IL-17) is one such pro-inflammatory cy-
tokine that is involved in causing loss of alveolar bone in 
periodontitis.12 This cytokine is produced by activated 
CD4 + T cells13,14 and neutrophils.15,16 IL-17 expression 
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Introduction: The aim of this study was to evaluate the efficacy of combination therapy 
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was reported to be increased in gingivitis.17 Its expression 
was also reported to be increased in gingival crevicular 
fluid (GCF) obtained from sites with periodontitis.18 GCF 
levels of IL-17 significantly reduced following nonsurgi-
cal periodontal therapy.19,20 Thus IL-17 serves as a useful 
marker indicative of disease states.21
As limited data exist on combined therapy of laser and 
PDT in the treatment of patients with periodontitis, this 
study aims to compare the efficacy of combination ther-
apy of diode laser and PDT as an adjunct to SRP in the 
treatment of chronic periodontitis and use the above de-




Thirty Indian adults (19 males and 11 females with a 
mean age of 38.03 years) were recruited from the Mahat-
ma Gandhi Mission’s Dental College and Hospital, Navi 
Mumbai. Inclusion criteria were (i) subjects aged 30-49 
years, (ii) dentition with at least 20 functional teeth, and 
(iii) subjects with chronic periodontitis having more than 
two nonadjacent sites with probing pocket depth (PPD) 
>5 mm, interproximal attachment loss of >3 mm and ra-
diographic evidence of alveolar bone loss. Exclusion cri-
teria were (i) subjects with diabetes mellitus, rheumatoid 
arthritis, irritable bowel disease, pulmonary disease, mul-
tiple sclerosis, bacterial, viral and fungal infections, (ii) 
subjects who have received any form of periodontal ther-
apy within the past 6 months, (iii) subjects with aggressive 
periodontitis, (iv) subjects who have received antibiotic 
therapy within the past 6 months, (v) subjects on anti-in-
flammatory drug regimen during the past 6 months, (vi) 
the presence of pulpal or periapical involvement on qual-
ifying teeth, (vii) subjects who have received orthodontic 
treatment in the past 6 months, (viii) pregnant and lactat-
ing women, (ix) physically and mentally challenged sub-
jects, and (x) Smokers. All subjects were informed about 
the study and gave their consent for the study. 
Study Design and Periodontal Examination
The present study was a split mouth double blinded, pro-
spective cohort, and randomized controlled clinical trial. 
An experienced clinician (MR) who was blinded to the 
study procedure collected all clinical data at the baseline 
and during follow-up visits while another experienced 
periodontist carried out the desired treatment proce-
dures. Ten patients with probing depth (PD) >5 mm on 
>1 aspect of each tooth, who were not included in the 
study were recruited for calibration of the main examiner 
(MR). The examiner recorded full-mouth PDs at six sites 
per tooth (excluding the third molars) in two different 
sessions on these subjects, using a UNC-15 probe. Upon 
completion of all measurements, the intraexaminer re-
peatability for PD measurement was assessed. Calibration 
was accepted if the measured parameters at two appoint-
ments were similar at a >90% level. At the initial visit all 
subjects underwent full-mouth periodontal examination 
and based on the inclusion criteria, teeth were randomly 
allocated to the test group (SRP plus combined therapy 
using diode laser and PDT) or control group (SRP alone). 
The subjects then received one stage full mouth SRP un-
der local anesthesia (2% lignocaine with 1:80 000 adrena-
line) using ultrasonic scaler (Satelec, Suprasson Newron, 
France) and/or Gracey curettes (Hu-Friedy #1-14, USA) 
and routine oral hygiene instructions. Full mouth algi-
nate impressions were made and poured in dental stone 
to make the diagnostic cast on which customized acryl-
ic stents was fabricated. These stents were used to assure 
reproducible measuring points for PPD and relative at-
tachment levels (RALs). The patients were recalled after 
1 week for collection of GCF to assess the levels of IL-17, 
which was recorded as our baseline data. Clinical param-
eters namely PD, RAL, BOP and gingival index (GI) were 
also recorded. After removal of supragingival plaque, 
therapy using diode laser and PDT was performed for 
the test teeth. GCF samples were again collected after 
3 months to assess the levels of IL-17. Clinical parame-
ters were recorded at 1 month and 3 months respectively 
(Figure 1).
Gingival Crevicular Fluid Sampling and Assay
Supragingival plaque was removed and teeth were iso-
lated using cotton rolls, microcapillary pipette was used 
for collection of GCF by placing it extra crevicular at the 
entrance of the gingival sulcus. Blood-contaminated sam-
The subjects then received one stage full mouth SRP under local anesthesia (2% lignocaine with 
1:80000 adrenaline) using ultrasonic scaler (Satelec, Suprasson Newron, France) and/or Gracey 
curettes (Hu-Friedy #1-14, USA) and routine oral hygiene instructions. Full mouth alginate 
impressions were made and poured in dental stone to make the diagnostic cast on which 
customized acrylic stents was fabricated. These stents were used to assure reproducible 
measuring points for PPD and relative attachment levels (RALs). The patients were recalled after 
1 week for collection of GCF to assess the levels of IL-17, which was recorded as our baseline 
data. Clinical parameters namely PD, RAL, BOP and gingival index (GI) were also recorded.  
After removal of supragingival plaque, therapy using diode laser and PDT was performed for the 
test teeth. GCF samples were again collected after 3 months to assess the levels of IL-17. 
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Figure 1. Study Design. Abbreviations: SRP, scaling and root planning; GCF, gingival crevicular fluid; PDT, photodynamic therapy.
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ples were discarded. Five microliters of GCF was collect-
ed from each site, placed in 100 µL of sterile phosphate 
buffered saline (pH 7.2) in Eppendorf tubes. The samples 
were stored at -70ºC. IL-17 was analyzed using an ELI-
SA kit (Human IL-17A (homodimer) ELISA Ready-SET-
Go!® From eBioscience), and values were presented as 
pg/µL.
Recording of Clinical Parameters
PD was measured at six sites per tooth i.e., mesiobuccal, 
midbuccal, distobuccal, mesiolingual, midlingual and 
distolingual, from the gingival margin to the base of the 
gingival pocket using a UNC-15 probe (Hu-Friedy, USA).
RAL was measured as the distance from a fixed reference 
point (FRP) on the customized acrylic stent to the base of 
the pocket with a UNC-15 probe.
BOP was recorded using Ainamo and Bay index (1975) 
and GI by Loe and Silness (1963).
Adjunctive Laser Treatments
After collection of GCF and recording of clinical param-
eters, the test teeth underwent therapy using diode laser 
and PDT. Topical anesthetic gel (2% lignocaine Hydro-
chloride, Neon Laboratories Limited, India) was applied 
around the concerned teeth and then washed off after 5 
minutes with the help of sterile saline. The test teeth first 
underwent laser therapy using 810 nm diode laser (The 
Picasso diode laser, AMD Lasers, USA). The laser beam 
was delivered into the periodontal pocket using a 400 µm 
fiber optic tip in contact mode from apical to coronal di-
rection using a sweeping motion for 1 minute using 1 W 
as a continuous wave.22 Thermal injury was minimized by 
keeping the tip in constant motion throughout the proce-
dure. Also, diode laser (λ = 810 nm) has a low tissue pene-
tration allowing complete removal of the gingival epithe-
lium with minimal damage to lamina propria.23
 Following which, the same teeth underwent PDT. The 
periodontal pocket was flooded with 2 mL of 1% meth-
ylene blue (S D Fine-Chem Limited, India) from the api-
cal to coronal end of the pocket with the help of a blunt 
cannula. Three minutes later, the pocket was thoroughly 
rinsed with saline to remove excess photosensitizer. Fol-
lowing this, an 810 nm diode laser was operated at 0.1 
W using a 400 µm fiber optic tip as a continuous wave. 
The tip was introduced in contact mode at the base of the 
periodontal pocket from where it was moved in coronal 
direction using sweeping motion for 1 minute followed by 
additional vertical movements in apical and coronal di-
rections for 30 seconds. The laser therapy was performed 
by an experienced periodontist who was not involved in 
the periodontal examination and data collection. The 
patient, operator, and dental assistant used safety glasses 
for protection of the eyes from the laser beam. The laser 
therapy was carried out in a closed operatory room, with a 
warning sign at the door to inform those outside.
Statistical Analysis
The distributions of the parameters were checked for nor-
mality using the one-sample Kolmogorov-Smirnov test. 
Because not all data were normally distributed, a decision 
was taken to use non-parametric tests. To test the mean 
equality of the two groups with respect to IL-17 level in 
GCF and the clinical parameters, Kruskal-Wallis was car-
ried out at 5% level of significance. To compare the chang-
es in the IL-17 level in GCF, PD, RAL, BOP, GI at 3 time 
intervals within test and control groups, Wilcoxon signed 
rank test was performed. Pair wise comparison of groups 
at various time intervals was done using Mann-Whitney 
U test. Differences were considered as statistically signif-
icant at P < 0.05. The statistical analysis was done using 
SPSS software (SPSS for Windows, release 16.0; SPSS Inc., 
Chicago, IL, USA).
Results
Thirty patients (19 males and 11 females, mean age 38.03) 
participated in the study. There were no dropouts in the 
study. Overall, 60 sites (30 test and 30 control) were eval-
uated for IL-17 levels in GCF.
The results for IL-17levels in GCF for both groups at base-
line and 3 months are presented in Table 1 and Figure 2. 
A significant reduction in IL-17 level was seen in both 
test and control groups 3 months after the treatment 
(P < 0.05). However, when comparing both groups no sta-
tistically significant difference was seen.
The PPD and RAL results (mean ± SD) for both groups at 
baseline, 1 month and 3 months are presented in Table 2. 
Throughout the study a significant reduction of the PD 
and a significant gain of RAL took place in both groups 
(P < 0.05; Table 2, Figures 3 and 4). However, no statisti-
cal significant difference was seen when comparing both 
groups at 3 time intervals i.e., baseline, 1 month and 3 
Table 1. IL-17 Level in GCF: Mean Scores (± SD; N= 30 patients) 
at Baseline and 3 Months
Treatment Baseline (± SD) 3 Months (± SD) P Value
IL-17 levels
Test teeth 687.12 ± 714.37 244.14 ± 205.48 *
Control teeth 576.19 ± 509.32 186.58 ± 107.94 *
P value NS NS


























Figure 2. Comparison of Level IL-17 in GCF Over 3-Month Time 
Period. 
Journal of Lasers in Medical Sciences  Volume 7, Number 4, Autumn 2016 253
     Combination Therapy Using Diode Laser and Photodynamic Therapy in Treatment of Chronic Periodontitis
months (Table 2).
The BOP and GI results (mean + SD) for both groups at 
baseline, 1 month and 3 months are presented in Table 3, 
Figures 5, and 6. A significant reduction in BOP and the 
GI was seen in both groups after 1 month and 3 months of 
therapy. However the best reduction in BOP and GI was 
seen in test group as compared to control group and it 
reached statistical significance (P < 0.05; Table 3).
Discussion
In the present study, we used combination therapy of di-
ode laser and PDT as an adjunct to SRP.
Diode laser helps to reduce subgingival microbiota thus 
providing sites for new connective tissue attachment.24 
It also helps in the promotion of hemostasis, has detox-
ifying effects and enhances healing. In addition, PDT 
using methylene blue dye exerts antimicrobial effect, by 
allowing methylene blue to enter gram-negative bacteria 
through the porin-protein channels of the outer mem-
brane which upon activation using diode laser, releases 
oxidizing metabolites that have harmful effects on lipo-
polysaccharide.25
Th1/Th2 paradigm has an important role in the host 
immune defense responses in chronic periodontitis.26 
However with the discovery of Th17 cells and Th17-re-
lated cytokines, pathogenesis of periodontitis has seen a 
new trend. We analyzed GCF levels of IL-17, at baseline 
and 3 months after the completion of treatment. IL-17 is 
a pro-inflammatory cytokine that is involved in causing 
an alveolar bone loss in periodontitis. Vernal et al report-
ed high levels of IL-17 in GCF and in the culture super-
natants of gingival cells of patients with periodontitis.18 
Takahashi et al also suggested an important role of IL-
17 in the pathogenesis of periodontal disease.21 We also 
Table 2. PPD and RAL: Mean Scores (± SD; N= 30 Patients) at Baseline, 1 Month and 3 Months
Treatment Baseline (± SD) 1 Month (± SD) 3 Months (± SD) P Value
PPD
Test teeth 5.03 ± 0.183 3.27 ± 0.450 3.07 ± 0.521 *
Control teeth 5.13 ± 0.346 3.27 ± 0.450 2.97 ± 0.490 *
P value NS NS NS
RAL
Test teeth 8.90 ± 0.960 7.13 ± 1.137 6.93 ± 1.112 *
Control teeth 8.97 ± 1.129 7.07 ± 1.048 6.77 ± 1.104 *
P value NS NS NS































Figure 3. Comparison of PPD Over the 3-Month Time Period. Figure 5. Comparison of BOP Over the 3-Month Time Period.
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reported a significant increase in levels of IL-17 in GCF 
in patients with chronic periodontitis. On the contrary 
a study by Pradeep et al found no significant relation-
ship between IL-17 and periodontitis.27 In our study, we 
found a statistical significant reductions in levels of IL-
17 in both treatment groups 3 months after treatment, 
however when comparing both treatment modalities no 
significant difference was found. This change in levels of 
IL-17 after treatment is in accordance with various oth-
er studies which also reported significant reductions in 
levels of IL-17 following treatment. Giannopoulou et al 
found statistically significant reductions in levels of IL-17 
after nonsurgical periodontal therapy with SRP, lasers and 
PDT.22 Zhao et al.also found statistically significant reduc-
tions in levels of IL-17 after SRP.19 Shirmohammadi et al 
also found statistically significant reductions in levels of 
IL-17 after one stage full mouth disinfection and SRP.20
Our study results also showed statistically significant re-
ductions in PDs and RALs in both test and control groups 
at 1 month and 3 months intervals. When comparing the 
test and control groups, no statistically significant results 
were found in respect to PDs reductions and RALs gains. 
This is in accordance with various studies where no sta-
tistically significant difference in reduction in PDs and 
gain in attachment levels were seen in the test group when 
compared to control groups after an additional treatment 
using PDT.10,28-31 However our results are not in keeping 
with a number of recent clinical investigations, which 
yielded significantly better clinical results for SRP in con-
junction with adjunctive PDT than for SRP alone.8,9,32
Test teeth showed a significantly greater reduction in the 
percentage of sites with BOP compared with control teeth 
at 1 month and 3 months after treatment. Similar results 
were obtained by Lui et al when they combined low level 
laser therapy and PDT.10 This is in accordance with var-
ious other studies which also reported significant great-
er reductions in BOP after adjunctive use of PDT.9,29,30,32 
Moritz et al showed a significant reduction in bacteria 
and inflammation when he combined diode laser thera-
py with SRP.24 This is in contrast to various other stud-
ies which failed to note significant greater improvements 
after adjunctive use of PDT.22,28 Another notable effect 
was the statistically significant reduction in GI in the test 
group after one month and three months. Similar changes 
in GI were reported by de Oliveira et al and Yilmaz et al 
after PDT as compared to SRP.31,33
On the basis of our results, we suggest that reduction in 
IL-17 levels of GCF after combined therapy using diode 
laser and PDT or SRP corresponds to the clinical im-
provements seen in the periodontal status and it can be 
used as a potential marker of periodontal disease activi-
ty. Further use of combined therapy with diode laser and 
PDT may provide additional benefit as they may help in 
reduction of key virulence factors such as lipopolysac-
charide and proteases.34 However, at present there is no 
established protocol for use of lasers as an adjunct to SRP. 
Therefore, more studies are required to establish an effec-
tive treatment protocol of the combination of this treat-
ment modality in the treatment of patients with chronic 
periodontitis.
Conclusion
The results show that, both treatment modalities resulted 
in significant decrease in level of IL-17 in GCF in patients 
with chronic periodontitis suggesting the efficacy of com-
bination therapy of diode laser and PDT as an adjunct to 
SRP on reducing levels of IL-17 in GCF in patients with 
chronic periodontitis.
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